CD9 expression in minimal change disease and focal segmental glomerulosclerosis. [PDF]
Christiadi D +4 more
europepmc +1 more source
Familial focal segmental glomerulosclerosis in infancy
A Bakkaloğlu +4 more
doaj
Efficacy of Rituximab as Adjunctive Therapy to Immunosuppressive Agents in Adult Primary Focal Segmental Glomerulosclerosis. [PDF]
Mohamed ON +16 more
europepmc +1 more source
Advances in the pathophysiology and treatment of focal segmental glomerulosclerosis: The importance of a timely and tailored approach. [PDF]
Gembillo G, Sessa C, Santoro D.
europepmc +1 more source
Case Report: Pneumomediastinum and pulmonary embolism in a 19-year-old with focal segmental glomerulosclerosis: a rare double-complication of corticosteroid therapy. [PDF]
Rotaru DE, Achim A.
europepmc +1 more source
Removal of comPlement factor D by adsorption on polymethylmethacrylate dialysis membranes [PDF]
Pannatier, J. G. +3 more
core
Efficacy and Safety of Rituximab in Treating Adult Patients with Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Prospective Study Compared with Glucocorticoids. [PDF]
Zhao YX, Li X, Cheng X, Pan Y, Liu L.
europepmc +1 more source
Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective. [PDF]
Bindra J +5 more
europepmc +1 more source
Liquid-liquid phase separation-related genes in the immune microenvironment and diagnosis of focal segmental glomerulosclerosis and minimal change disease. [PDF]
Lu H, Sun J, Sun J.
europepmc +1 more source
ECHS1 as a Lipid Metabolism Biomarker for Pediatric Focal Segmental Glomerulosclerosis. [PDF]
He C, Peng W, Li S, Xu C, Chen X, Qin Y.
europepmc +1 more source

